Leber Hereditary Optic Neuropathy Archives

BridgeBio Receives Almost 300 Million for Continued Rare Disease Research

Post Author:Trudy Horsting
Post published:February 11, 2019
Post Category:Achondroplasia / Amyloidosis / Leber Hereditary Optic Neuropathy / Pantothenate kinase-associated neurodegenerat
Post Comments:0 Comments

About BridgeBio Pharma BridgeBio Pharmaceuticals was created in 2015 by veterans from the fields of academia and biotechnology. The company focuses on the development of new therapeutic treatments for genetic…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

SIGN UP FOR OUR NEWSLETTER
Email Address

Let’s Work Together!

Keep Up to Date

Learn More